Delivery Order SPE2DB22D3501-SPE2DB23FWJ23
Award Date 7/11/23
Potential Completion Date 7/12/23
Potential Value $3.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $98,166 delivery order to Amerisourcebergen Drug Corporation for 400 mg/20 ml vials of ACTEMRA. As a prime contractor for DLA's pharmaceutical contracts, Amerisourcebergen will deliver approximately 20 vials of the rheumatoid arthritis medication to a facility in Conshohocken, Pennsylvania under a firm fixed price arrangement. The order was placed under an existing DLA pharmaceutical supply vehicle and runs from August 21-22, 2023 to support the medical...
- The Defense Logistics Agency Troop Support Medical awarded a $22,188.78 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 400 milligram/20 milliliter vials of ACTEMRA. The delivery order was issued against an indefinite-delivery/indefinite-quantity contract vehicle and calls for Amerisourcebergen to provide 20 milliliter vials of ACTEMRA, an interleukin-6 receptor antagonist used to treat rheumatoid arthritis, from its facility in Conshohocken, Pennsylvania for delivery...
- Defense Logistics Agency Troop Support Medical awarded a $3,447.20 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for 4562520926 ACTEMRA 162 MG/0.9 ML SYRINGE. The delivery order was awarded on October 17, 2023 with an anticipated completion date of October 18, 2023. Performance will take place in Conshohocken, Pennsylvania. No set-aside designation was used for this procurement. ACTEMRA is a medication used to treat certain types...
- The Defense Logistics Agency Troop Support Medical awarded a $4,401.62 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562180902 ACTEMRA 80 MG/4 ML VIAL 4ML. The place of performance is Conshohocken, Pennsylvania. The period of performance is September 14-15, 2023. This delivery order was issued against an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products in support of the Defense Logistics Agency's medical logistics programs....
- The Defense Logistics Agency awarded a delivery order valued at $3,386.42 to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Actemra 400 mg/20 ml vials. This firm fixed-price delivery order is scheduled for completion by September 2, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $7,194.60 to AmerisourceBergen Drug Corp for the supply of Actemra 162 mg/0.9 mL syringes on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed price delivery order, which was competitively awarded without set-aside designation, will be performed at the company's corporate headquarters in Conshohocken, Pennsylvania. Actemra is a biologic immunosuppressant medication commonly used in the treatment...
- The Defense Logistics Agency awarded a $5,761.27 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of ACTEMRA 162 mg/0.9 mL syringes. The award, with an ultimate completion date of September 9, 2025, represents a non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending...
- The Defense Logistics Agency awarded a delivery order valued at $3,529.18 to AmerisourceBergen Drug Corp for the supply of ACTEMRA 200 mg/10 mL vials on July 21, 2025, with completion scheduled for July 22, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. ACTEMRA (tocilizumab) is a biologic immunosuppressant used in treating rheumatoid...
- The Defense Logistics Agency awarded a $2,877.84 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Actemra 162 mg/0.9 mL syringes on August 5, 2025, with an ultimate completion date of August 6, 2025. This non-set-aside contract represents a pharmaceutical delivery to be performed at the contractor's facility in Conshohocken, Pennsylvania. Actemra is a biologic immunosuppressant used to treat rheumatoid arthritis and other inflammatory conditions, making this a...
- The Defense Logistics Agency awarded a delivery order valued at $1,647.70 to AmerisourceBergen Drug Corp for Actemra 200 mg/10 ml vials on September 18, 2025, with completion targeted for September 19, 2025. This firm fixed-price delivery order utilizes no set-aside designation and represents a competitive award to the major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The contract calls for delivery of the specified pharmaceutical product to the company's place of...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB23FWJ23Delivery Order
The Defense Logistics Agency awarded a $3,792.78 firm fixed price delivery order to Amerisourcebergen Drug Corporation for ACTEMRA 200 MG/10 ML vials. Under this order, Amerisourcebergen will deliver 10 ML vials of ACTEMRA, a medication used to treat rheumatoid arthritis, from its facility in Conshohocken, Pennsylvania. The single day order period is July 11 to July 12, 2023. No subcontractors or set aside designations were specified. This order was placed under an existing DLA pharmaceutical supply contract vehicle to support the Agency's medical material procurement programs.
Generated 12/19/23, 9:48 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.8k | 7/11/23 |